Sacral Neuromodulation (SNM), previously called sacral nerve stimulation (SNS), involves the stimulation of the sacral nerves to modulate the neural reflexes that influence the lower urinary and intestinal tracts. SNM is today a widely accepted treatment modality for pelvic floor dysfunctions. Since the first procedures performed in the 1980's by Tanagho and Schmidt, extensive research has established SNM as a treatment option for overactive bladder, non-obstructive retention, and fecal incontinence. Although the mechanisms of action are still not fully understood, SNM is thought to help normalize afferent sensory signaling from bladder and bowel to the brain, re-establishing voluntary control and restoring normal function. The therapy has been proven effective and safe in the long term leading to major improvement in quality of life for affected patients. As of December 2018, more than 300,000 patients have been implanted worldwide.

SNM is internationally endorsed. Professional physician societies and consensus guidelines all recommend SNM for patients with refractory overactive bladder and fecal incontinence.

A reference list of scientific publications is available through ECMT, please contact us if you wish to receive a copy.